Multiplex Photoluminescent Silicon Nanoprobe for Diagnostic Bioimaging and Intracellular Analysis

Abstract

Herein, a label‐free multiplex photoluminescent silicon nanoprobe (PLSN‐probe) is introduced as a potential substitute for quantum dots (QDs) in bioimaging. An inherently non‐photoluminescent silicon substrate is altered to create the PLSN‐probe, to overcome the major drawbacks of presently available QDs. Additionally, crystallinity alterations of the multiplane crystalline PLSN‐probes lead to broad absorption and multiplex fluorescence emissions, which are attributed to the simultaneous existence of multiple crystal planes. The PLSN‐probe not only demonstrates unique optical properties that can be exploited for bioimaging but also exhibits cell‐selective uptake that allows the differentiation and diagnosis of HeLa and fibroblast cells. Moreover, multiplex emissions of the PLSN‐probe illuminate different organelles such as the nucleus, nucleolemma, and cytoskeleton, depending on size‐based preferential uptake by the cell organs. This in vitro study reveals that cancerous HeLa cells have a higher propensity for taking up the PLSN‐probe compared to fibroblast cells, allowing the diagnosis of cancerous HeLa cells. Additionally, the fluorescence intensity per unit area of the cell is found to be a reliable means for distinguishing between dead and healthy cells. It is anticipated that the multifunctionality of the PLSN‐probes will lead to better insight into the use of such probes for bioimaging and diagnosis applications.

Nanomaterial-Based Dual-Emission Ratiometric Fluorescent Sensors for Biosensing and Cell Imaging

“…Attributed to their unique optical/electronic features, abundant sources, low toxicity, and benign biocompatibility, silicon-based nanomaterials have broad applications in the electronic and biomedicine industries, such as for biosensors, field-effect transistors, drug carriers, and light-emitting diodes [ 44 , 45 , 46 ]. Among them, fluorescent silicon nanodots (SiNDs) and nanorods have been applied for the design of ratiometric biosensors.…”

Biomedical Waste Management by Using Nanophotocatalysts: The Need for New Options

“…Nano-sized photocatalyst particles demonstrate a significantly intensified reactivity compared to larger particles or bulk materials due to their large surface area [29,30]. Novel nanophotocatalysts have been developed with the ability to exploit solar energy to synthesize organic compounds under controlled conditions [31].…”

Nanotechnology, Nanomedicine, and the Kidney

“…Nanotechnology refers to the use, or application, of engineered macromolecules in the size range of 1-100 nanometers [1]. Materials involved range from polymers, metals, macromolecules, lipids, semiconductors, and chemicals [2,3]. Due to their small size, nanomaterials, which contain more than 50% nanoparticles (NP), can exhibit novel physical (mechanical, optical, electrical, magnetic, and thermal) [4][5][6] properties that can add substantial value in a wide array of applications, including medicine [7], generating the portmanteau nanomedicine.…”